(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications...
Stats | |
---|---|
今日成交量 | 34.28M |
平均成交量 | 30.04M |
市值 | 289.72B |
EPS | CNY0.210 ( 2024-04-25 ) |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | 65.16 |
ATR14 | CNY0.0350 (0.08%) |
音量 相关性
Jiangsu Hengrui Medicine 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Jiangsu Hengrui Medicine 相关性 - 货币/商品
Jiangsu Hengrui Medicine 财务报表
Annual | 2023 |
营收: | CNY22.82B |
毛利润: | CNY19.29B (84.55 %) |
EPS: | CNY0.680 |
FY | 2023 |
营收: | CNY22.82B |
毛利润: | CNY19.29B (84.55 %) |
EPS: | CNY0.680 |
FY | 2022 |
营收: | CNY21.28B |
毛利润: | CNY17.79B (83.61 %) |
EPS: | CNY0.610 |
FY | 2021 |
营收: | CNY25.91B |
毛利润: | CNY22.16B (85.56 %) |
EPS: | CNY0.710 |
Financial Reports:
No articles found.
Jiangsu Hengrui Medicine
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, researches, develops, manufactures, and commercializes medicine worldwide. The company is developing Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403 for oncology, metabolic, pain, autoimmune, and other indications. The company was founded in 1970 and is based in Lianyungang, China.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。